DiaMedica Therapeutics Inc

DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type I or Type II diabetes; and Phase 2/3 REMEDY2 trials for the treatment of patients with acute ischemic stroke. Show More...

Website https://www.diamedica.com
Sector Healthcare
Industry Biotechnology
Last Quote 4.01 USD
Last Updated 14-07-2025
External Links Yahoo Finance Morningstar Ratios
Interest Coverage

The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia

	2010-12	2011-12	2012-12	2013-12	2014-12	2015-12	2016-12	2017-12	2018-12	2019-12	TTM
Earnings Per Share USD	-3.0	-2.94	-4.02	-2.63	-1.55	-0.4	-0.47	-0.72	-0.74	-0.89	-0.81
Dividends USD
Payout Ratio % *
Shares Mil	1.0	2.0	2.0	3.0	3.0	4.0	5.0	6.0	8.0	12.0	12.0
Book Value Per Share * USD	3.94			0.18	-0.23	-0.28	0.29		0.11	0.81	0.94
Free Cash Flow Per Share * USD	-1.7			-2.49	-1.4	-0.35	-0.47	-0.73	-0.68	-0.82
Return on Assets %	-82.66	-85.8	-197.59	-219.48	-302.27	-572.45	-212.2	-231.84	-56.94	-77.75	-65.79
Financial Leverage (Average)	1.06	1.06	1.7	2.1			1.5	2.26	1.08	1.19	1.08
Return on Equity %	-89.15	-91.24	-244.36	-406.48				-416.63	-64.34	-86.43	-72.14
Return on Invested Capital %	-89.15	-91.77	-245.29	-406.86				-416.63	-64.17	-85.73	-71.15
Interest Coverage		-524.79		-957.81		-31.54	-44.5
Current Ratio	5.67	7.5	1.56	1.72	0.15	0.2	2.96	1.49	13.87	6.7	15.15
Quick Ratio	5.52	7.41	1.49	1.66	0.12	0.16	2.85	1.43	13.58	6.6	14.58
Debt/Equity										0.02	0.010

DiaMedica Therapeutics Inc

Interest Coverage